Ascendis Pharma A (ASND) Income - Equity (2023 - 2026)
Ascendis Pharma A (ASND) reported Income - Equity of $4.46 million for the quarter ended Jun 30, 2026, compared with -$4.64 million a year earlier and down 62.8% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Income - Equity (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Income - Equity came in at $9.24 million; for the year ended Dec 31, 2025, it came in at -$18.42 million.
- By year, Income - Equity came in at $21.71 million in the year ended Dec 31, 2024 (+9.1%), $19.9 million in the year ended Dec 31, 2023 (+6.7%) and $18.65 million in the year ended Dec 31, 2022.
- Five-year quarterly Income - Equity spans a low of -$27.96 million in the quarter ended Mar 31, 2025 and a high of $12 million in the quarter ended Mar 31, 2026.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $12 million (quarter ended Mar 31, 2026), $1.55 million (quarter ended Dec 31, 2025) and -$8.77 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income - Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 4.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.46 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | -8.77 Mn |
| Jun 30, 2025 | -4.64 Mn |
| Mar 31, 2025 | -27.96 Mn |
| Dec 31, 2024 | -4.89 Mn |
| Sep 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -5.73 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | -3.15 Mn |
| Sep 30, 2023 | -7.40 Mn |
| Jun 30, 2023 | -8.11 Mn |
| Mar 31, 2023 | -1.32 Mn |
API Access
Ascendis Pharma A Income - Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-equity&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-equity", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-equity&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();